RossLiaoMD

Minimally Invasive Surgery, Stone Disease, Surgical Oncology

Urology Resident at Cleveland Clinic

Dr. Liao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Cleveland Clinic - Glickman Urological & Kidney Institute
9500 Euclid Ave., Q10
Cleveland, OH 44195

Dr. Ross Liao graduated junior phi beta kappa (top 1% of his class) from Johns Hopkins University with a Bachelor of Science degree (B.S.) in Molecular and Cellular Biology. He subsequently obtained his Doctor of Medicine degree (M.D.) from the prestigious Johns Hopkins School of Medicine. He is currently completing urology residency at Cleveland Clinic Glickman Urologic and Kidney Institute, the nation's largest and one of the most well-regarded urology departments. His clinical interests span the entire breadth of urology and include minimally invasive robotic and open surgery, stone disease, surgical oncology, and genitourinary reconstructive/prosthetic surgery. Dr. Liao has more than 12 peer-reviewed scientific publications in prestigious urologic journals including the Journal of Urology. He fluently speaks both English and Mandarin Chinese.

Cleveland Clinic FoundationResidency, Urology, 2020 - 2026
Johns Hopkins University School of MedicineClass of 2020
Johns Hopkins UniversityBS, Molecular and Cellular Biology, Summa Cum Laude, 2011 - 2015

Lester Persky Urologic Research Award Johns Hopkins Brady Urological Institute, 2016-2018

PubMed

Low baseline IsoPSA Index is associated with a Prolonged Low Risk of Clinically Significant Prostate Cancer Diagnosis in Men with an Elevated PSA.
Nour Abdallah, Rebecca A Campbell, Tarik Benidir, Andrew Wood, Zaeem Lone
Urology. 2025-01-15
1 citations
Emerging Insights in Small-Cell Carcinoma of the Genitourinary Tract: From Diagnosis to Novel Therapeutic Horizons.
Ross S Liao, Hui Ting Ruan, Albert Jang, Melissa Huynh, Rosa Nadal Rios
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2024-01-01
10 citations
Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution.
Jarrell Imamura, Shinjini Ganguly, Andrew Muskara, Ross S Liao, Jane K Nguyen
Frontiers in Endocrinology. 2023-01-01

Journal Articles

Emerging Insights in Small-Cell Carcinoma of the Genitourinary Tract: From Diagnosis to Novel Therapeutic Horizons
Ross S. Liao, Hui Ting Ruan, Albert Jang, Melissa Huynh, Rosa Nadal Rios, Jean H. Hoffman-Censits, Shuanzeng Wei, Omar Y. Mian, Pedro C. Barata, ASCO Ed Book, 1/4/2024
Contemporary Management of Bulbar Urethral Strictures
Ross S. Liao, MD, Erica Stern, BS, James E. Wright, MD, Andrew J. Cohen, MD, Reviews in Urology, 4/10/2021
Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer
David D’Andrea, Beat Foerster, Surena F. Matin, Ja H. Ku, Tim Muilwijk, Leonardo L. Monteiro, Ross Liao, Firas Petros, Philippe E. Spiess, Trinity J. Bivalacqua, Kees ..., European Urology Open Science

AUA 2018: Incidence of Lower Pathologic Stage in Patients Treated with Neoadjuvant Chemotherapy for High-Risk Upper Tract Urothelial CarcinomaMay 18th, 2018